Refine by MP, party, committee, province, or result type.
Veterans Affairs committee That's a really good question about a really important subject. As you know, access to cannabis is all that's been on my mind for the five years I've been in this. I continue to be asked by countries all over the world about this and about how we can solve this problem. We can't put clinics everywhere.
March 20th, 2019Committee meeting
Dr. Barry Waisglass
March 20th, 2019Committee meeting
Dr. Barry Waisglass
Veterans Affairs committee I just want to reiterate that THC is not a hallucinogenic, and there is no absolute formula. What is interesting about cannabis is that very small doses can work. We know that the average amount, in data from Israel, the Netherlands, and Canada, is about one milligram, 1.5 milligrams, or 0.67 milligrams in the Dutch study.
March 20th, 2019Committee meeting
Dr. Barry Waisglass
Veterans Affairs committee Cannabis is not a gateway drug. Anyone who says that is spewing out a lot of nonsense. There isn't a shred of legitimate evidence on the planet to support that. It's just rhetoric left over from the old “drug war” time. In fact, there is a good paper on that. It isn't at my fingertips right now—it's a pity I didn't have the questions in advance to prepare for that—but there is good evidence that it is not a gateway drug.
March 20th, 2019Committee meeting
Dr. Barry Waisglass
Veterans Affairs committee I don't have on the tip of my tongue case studies that would be like a testimonial to say this one worked and this one didn't work. There was no consistency in my experience of seeing veterans or anyone else with PTSD in terms of the drugs that worked or didn't work. I'm referring to cannabis drugs.
March 20th, 2019Committee meeting
Dr. Barry Waisglass
Veterans Affairs committee Aurora has several properties. One of them is CanniMed, which was the first of the licensed commercial producers. CanniMed is in our fold, so we work with the science people in that area too. Yes, we are collaborating with university centres and research centres in a number of provinces.
March 20th, 2019Committee meeting
Dr. Barry Waisglass
Veterans Affairs committee We're not doing that. I specifically asked the people in our companies about tracking that information. It's not being done. It would be far better to construct a specific study in that regard to gather that information. I don't know of anybody who is doing that, but it has value.
March 20th, 2019Committee meeting
Dr. Barry Waisglass
Veterans Affairs committee I have not.
March 20th, 2019Committee meeting
Dr. Barry Waisglass
March 20th, 2019Committee meeting
Dr. Barry Waisglass
Veterans Affairs committee I'm sorry, but because of volume issues I was unable to hear the first part of your question.
March 20th, 2019Committee meeting
Dr. Barry Waisglass
Veterans Affairs committee Which responds better depends on what study you look at, and I don't think it's important. Whether it's PTSD or chronic pain or anxiety or insomnia, cannabis works for all of those different problems. What I would like to address is the other part of your question, about the specificity or the matching.
March 20th, 2019Committee meeting
Dr. Barry Waisglass
Veterans Affairs committee Absolutely.
March 20th, 2019Committee meeting
Dr. Barry Waisglass
Veterans Affairs committee Perhaps you will allow me to add just one more thing.
March 20th, 2019Committee meeting
Dr. Barry Waisglass
Veterans Affairs committee When you're doing this, you have to keep in mind that cannabis is a botanical. It's a herb. It's not the same. It's very difficult, when you're assessing the science on it, to consider that. If you want to look at what cannabis will do, look at the pharmaceutical products that have evolved from cannabis, or that are pure extracts, such as nabiximols, and look at the science on that.
March 20th, 2019Committee meeting
Dr. Barry Waisglass
March 20th, 2019Committee meeting
Dr. Barry Waisglass